vs
Side-by-side financial comparison of DYNEX CAPITAL INC (DX) and Inogen Inc (INGN). Click either name above to swap in a different company.
Inogen Inc is the larger business by last-quarter revenue ($68.6M vs $43.5M, roughly 1.6× DYNEX CAPITAL INC). On growth, DYNEX CAPITAL INC posted the faster year-over-year revenue change (531.3% vs 3.4%). Over the past eight quarters, DYNEX CAPITAL INC's revenue compounded faster (75.8% CAGR vs 4.2%).
Dynex Capital Inc. is a publicly traded real estate investment trust headquartered in the United States. It specializes in investing in and managing a diversified portfolio of mortgage-backed securities, residential and commercial mortgage loans, and other mortgage-related assets. It delivers consistent returns to shareholders via regular dividends and long-term capital growth.
Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.
DX vs INGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.5M | $68.6M |
| Net Profit | — | — |
| Gross Margin | — | 51.4% |
| Operating Margin | — | -13.6% |
| Net Margin | — | — |
| Revenue YoY | 531.3% | 3.4% |
| Net Profit YoY | — | — |
| EPS (diluted) | $1.59 | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.5M | $68.6M | ||
| Q3 25 | $30.6M | $79.1M | ||
| Q2 25 | $23.1M | $79.2M | ||
| Q1 25 | $17.1M | $68.5M | ||
| Q4 24 | — | $66.3M | ||
| Q3 24 | — | $74.9M | ||
| Q2 24 | — | $74.4M | ||
| Q1 24 | $-3.2M | $63.1M |
| Q4 25 | — | — | ||
| Q3 25 | $150.4M | $-5.3M | ||
| Q2 25 | $-13.6M | $-4.2M | ||
| Q1 25 | $-3.1M | $-6.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-6.0M | ||
| Q2 24 | — | $-5.6M | ||
| Q1 24 | $40.1M | $-14.6M |
| Q4 25 | — | 51.4% | ||
| Q3 25 | — | 52.2% | ||
| Q2 25 | — | 52.2% | ||
| Q1 25 | — | 53.1% | ||
| Q4 24 | — | 54.7% | ||
| Q3 24 | — | 55.2% | ||
| Q2 24 | — | 57.4% | ||
| Q1 24 | — | 54.5% |
| Q4 25 | — | -13.6% | ||
| Q3 25 | — | -9.0% | ||
| Q2 25 | — | -7.7% | ||
| Q1 25 | — | -11.2% | ||
| Q4 24 | — | -17.2% | ||
| Q3 24 | — | -10.4% | ||
| Q2 24 | — | -9.5% | ||
| Q1 24 | — | -25.8% |
| Q4 25 | — | — | ||
| Q3 25 | 491.3% | -6.7% | ||
| Q2 25 | -58.8% | -5.2% | ||
| Q1 25 | -18.0% | -9.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -8.0% | ||
| Q2 24 | — | -7.5% | ||
| Q1 24 | -1256.8% | -23.1% |
| Q4 25 | $1.59 | $-0.26 | ||
| Q3 25 | $1.08 | $-0.20 | ||
| Q2 25 | $-0.14 | $-0.15 | ||
| Q1 25 | $-0.06 | $-0.25 | ||
| Q4 24 | — | $-0.41 | ||
| Q3 24 | — | $-0.25 | ||
| Q2 24 | — | $-0.24 | ||
| Q1 24 | $0.64 | $-0.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $531.0M | $103.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.5B | $192.2M |
| Total Assets | $17.3B | $298.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $531.0M | $103.7M | ||
| Q3 25 | $491.0M | $106.5M | ||
| Q2 25 | $387.5M | $103.7M | ||
| Q1 25 | $327.4M | $118.9M | ||
| Q4 24 | — | $113.8M | ||
| Q3 24 | — | $105.7M | ||
| Q2 24 | — | $97.9M | ||
| Q1 24 | $295.7M | $107.4M |
| Q4 25 | $2.5B | $192.2M | ||
| Q3 25 | $2.0B | $197.2M | ||
| Q2 25 | $1.6B | $199.5M | ||
| Q1 25 | $1.4B | $198.0M | ||
| Q4 24 | — | $173.9M | ||
| Q3 24 | — | $185.4M | ||
| Q2 24 | — | $187.6M | ||
| Q1 24 | $958.5M | $191.9M |
| Q4 25 | $17.3B | $298.6M | ||
| Q3 25 | $14.2B | $307.0M | ||
| Q2 25 | $11.3B | $312.0M | ||
| Q1 25 | $9.0B | $308.4M | ||
| Q4 24 | — | $296.2M | ||
| Q3 24 | — | $306.2M | ||
| Q2 24 | — | $308.9M | ||
| Q1 24 | $6.3B | $315.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $120.8M | $-943.0K |
| Free Cash FlowOCF − Capex | — | $-1.9M |
| FCF MarginFCF / Revenue | — | -2.8% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $120.8M | $-943.0K | ||
| Q3 25 | $68.3M | $2.2M | ||
| Q2 25 | $31.9M | $4.3M | ||
| Q1 25 | $6.4M | $-16.8M | ||
| Q4 24 | — | $-3.0M | ||
| Q3 24 | — | $7.0M | ||
| Q2 24 | — | $6.7M | ||
| Q1 24 | $-17.1M | $-4.7M |
| Q4 25 | — | $-1.9M | ||
| Q3 25 | — | $1.6M | ||
| Q2 25 | — | $3.7M | ||
| Q1 25 | — | $-17.1M | ||
| Q4 24 | — | $-3.3M | ||
| Q3 24 | — | $5.3M | ||
| Q2 24 | — | $6.6M | ||
| Q1 24 | — | $-6.1M |
| Q4 25 | — | -2.8% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | -24.9% | ||
| Q4 24 | — | -5.0% | ||
| Q3 24 | — | 7.1% | ||
| Q2 24 | — | 8.9% | ||
| Q1 24 | — | -9.6% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | — | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.43× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DX
Segment breakdown not available.
INGN
| Other | $36.1M | 53% |
| Non Us | $32.5M | 47% |
